Nexentis unit achieves drug discovery milestone with improved molecule May 18, 2026 09:34AM
Nexentis subsidiary hits drug discovery milestone for cancer treatment May 18, 2026 09:31AM
Nexentis subsidiary achieves drug discovery milestone May 13, 2026 07:07AM
Nexentis receives U.S. trademark registration for MITOLINE algorithm May 5, 2026 07:32AM
Nexentis Technologies (NXTS) files $100M mixed shelf Apr 16, 2026 04:18PM